| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |